Olink Bioscience appoints Simon Fredriksson Ph.D. as Executive Vice President

Uppsala, Sweden – Simon Fredriksson co-founder and CSO of Olink AB has today been promoted to executive Vice President. With the new appointment follow increased responsibilities for global business development and external research collaborations. Dr Fredriksson, one of the founding scientists of Olink has over the last 7 years significantly contributed to the development of [...]

Esco Chosen to Supply Centre for Regenerative Medicine

In March 2011 Esco GB, in co-operation with one of its major distributors, delivered and installed a range of microbiological safety cabinets and fume cupboards at The University of Edinburgh, Scottish Centre for Regenerative Medicine (SCRM). The Centre brings together world leading stem cell research with established clinical excellence to deliver a 'bench-to-bedside' approach aimed [...]

Incubators Facilitate Research Under Hypoxic Conditions

BOHEMIA, N.Y. - BINDER CB series incubators provide excellent growth conditions for mammalian cell and tissue cultures, offering precise, reproducible control of oxygen concentrations as low as 0.2% and quick recovery times, important factors in conducting research under hypoxic conditions. Models CB 53, 150 and 210 (model numbers refer to chamber volume in liters) allow [...]

Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists – Provides Community Most Complete Assembly to Date

BRANFORD, Connecticut - The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences' benchtop GS Junior sequencing system to generate the "most accurate and detailed genetic analysis to date" of this particularly virulent strain.[1] The sequencing was performed by scientists at the UK's [...]

Harvard Apparatus Expands Global Reach with Opening of India Liaison Office

Holliston, Massachusetts, USA: Scientific instrument manufacturer, Harvard Apparatus, is pleased to announce the opening of their India Liaison Office in New Delhi this June, 2011 headed by Dr. Asit Dutta. Based in New Delhi, Dr. Dutta will be responsible for expanding sales of all Harvard Apparatus products through a network of distribution channels across India. [...]

Cell Line Genetics and Ambry Genetics Announce Exclusive Global Agreement For Sales of Ambry Genetics’ StemArray™ and Related Services

MADISON, Wis. & NEW YORK & ALISO VIEJO, Calif. - Cell Line Genetics, Inc., a leader in Stem Cell Quality Assurance services and products, and Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announced today an exclusive agreement under which Cell Line Genetics will sell the Ambry [...]

Preliminary Injunction Order Against FEI Japan

Tokyo District Court issued a preliminary injunction ordering FEI Japan not to make, sell, assign, lease, offer for assignment or lease, display for the purpose of assignment or lease, or import the products below. The order was to grant Hitachi High-Technologies’ motion, which was filed December 15, 2010, in Tokyo District Court. In the motion, [...]

ProImmune Launches ProArray Ultra: A New Protein and Peptide Microarray Platform with True Analytical Grade Performance

OXFORD, England - ProImmune Ltd., a leader in services for understanding immune responses, announced today that it has launched ProArray Ultra™, a uniquely powerful protein and peptide array platform, which is more sensitive than optimized ECL ELISA. The new platform allows analysis of more than 30,000 peptides or proteins at once, and typically requires only [...]

Moulder Center for Drug Discovery Research Selects Tripos Software for Drug Design

ST LOUIS - Tripos, a leading provider of molecular modeling and informatics software to improve productivity and decision-making in drug discovery, announced today that the Moulder Center for Drug Discovery Research in Temple University’s School of Pharmacy has licensed its entire computer-aided drug design (CADD) and informatics software portfolio to accelerate the drug discovery process. [...]

Pressure BioSciences, Inc. Granted Extension to October 3, 2011 to Regain Compliance With NASDAQ Minimum Stockholders’ Equity Requirement

SOUTH EASTON, Mass. - Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that the Company received a notice from NASDAQ on June 10, 2011 granting it an extension of time until October 3, 2011 to regain compliance with the NASDAQ minimum stockholders' equity requirement of $2.5 million. On April 6, 2011, the Company [...]

Access IBO on Knowledge Center